BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 19788911)

  • 1. The C1 homodimer of adenylyl cyclase binds nucleotides with high affinity but possesses exceedingly low catalytic activity.
    Suryanarayana S; Pinto C; Mou TC; Richter M; Lushington GH; Seifert R
    Neurosci Lett; 2009 Dec; 467(1):1-5. PubMed ID: 19788911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of the interaction of Bordetella pertussis adenylyl cyclase with fluorescent nucleotides.
    Göttle M; Dove S; Steindel P; Shen Y; Tang WJ; Geduhn J; König B; Seifert R
    Mol Pharmacol; 2007 Sep; 72(3):526-35. PubMed ID: 17553924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential interactions of G-proteins and adenylyl cyclase with nucleoside 5'-triphosphates, nucleoside 5'-[gamma-thio]triphosphates and nucleoside 5'-[beta,gamma-imido]triphosphates.
    Gille A; Guo J; Mou TC; Doughty MB; Lushington GH; Seifert R
    Biochem Pharmacol; 2005 Dec; 71(1-2):89-97. PubMed ID: 16271707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The C2 catalytic domain of adenylyl cyclase contains the second metal ion (Mn2+) binding site.
    Mitterauer T; Hohenegger M; Tang WJ; Nanoff C; Freissmuth M
    Biochemistry; 1998 Nov; 37(46):16183-91. PubMed ID: 9819210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of adenylyl cyclase activity using a fluorescent ATP substrate and capillary electrophoresis.
    Cunliffe JM; Sunahara RK; Kennedy RT
    Anal Chem; 2006 Mar; 78(6):1731-8. PubMed ID: 16536404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential inhibition of adenylyl cyclase isoforms and soluble guanylyl cyclase by purine and pyrimidine nucleotides.
    Gille A; Lushington GH; Mou TC; Doughty MB; Johnson RA; Seifert R
    J Biol Chem; 2004 May; 279(19):19955-69. PubMed ID: 14981084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships for the interactions of 2'- and 3'-(O)-(N-methyl)anthraniloyl-substituted purine and pyrimidine nucleotides with mammalian adenylyl cyclases.
    Pinto C; Lushington GH; Richter M; Gille A; Geduhn J; König B; Mou TC; Sprang SR; Seifert R
    Biochem Pharmacol; 2011 Aug; 82(4):358-70. PubMed ID: 21620805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic insights in light-induced cAMP production by photoactivated adenylyl cyclase alpha (PACalpha).
    Looser J; Schröder-Lang S; Hegemann P; Nagel G
    Biol Chem; 2009 Nov; 390(11):1105-11. PubMed ID: 19747080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine A1 receptor-dependent and -independent effects of the allosteric enhancer PD 81,723.
    Musser B; Mudumbi RV; Liu J; Olson RD; Vestal RE
    J Pharmacol Exp Ther; 1999 Feb; 288(2):446-54. PubMed ID: 9918544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential interactions of the catalytic subunits of adenylyl cyclase with forskolin analogs.
    Pinto C; Hübner M; Gille A; Richter M; Mou TC; Sprang SR; Seifert R
    Biochem Pharmacol; 2009 Jul; 78(1):62-9. PubMed ID: 19447224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit.
    Zeiders JL; Seidler FJ; Slotkin TA
    J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrphostins are inhibitors of guanylyl and adenylyl cyclases.
    Jaleel M; Shenoy AR; Visweswariah SS
    Biochemistry; 2004 Jun; 43(25):8247-55. PubMed ID: 15209521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the adenylyl cyclase catalytic core.
    Zhang G; Liu Y; Ruoho AE; Hurley JH
    Nature; 1997 Mar; 386(6622):247-53. PubMed ID: 9069282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular mechanisms of action of dendrons, containing 48-60 sequence of HIV-1 TAT-protein, on the functional activity of the adenylyl cyclase signaling systems].
    Shpakov AO; Gur'ianov IA; Avdeeva EV; Vorob'ev VI; Vlasov GP
    Tsitologiia; 2004; 46(11):1011-22. PubMed ID: 15704884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular mechanisms of regulatory action of adrenergic receptor agonists on functional activity of adenylyl cyclase signaling system of the ciliates Dileptus anser and Tetrahymena pyriformis].
    Shpakov AO; Derkach KV; Uspenskaia ZI; Shpakova EA; Kuznetsova LA; Plesneva SA; Pertseva MN
    Tsitologiia; 2004; 46(4):317-25. PubMed ID: 15346790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins.
    Selley DE; Breivogel CS; Childers SR
    Mol Pharmacol; 1993 Oct; 44(4):731-41. PubMed ID: 8232223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-steady state study of beta-adrenergic and purinergic receptor interaction in C6 cell membranes: undelayed balance between positive and negative coupling to adenylyl cyclase.
    Valeins H; Merle M; Labouesse J
    Mol Pharmacol; 1992 Dec; 42(6):1033-41. PubMed ID: 1336111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of the guanine nucleotide exchange reaction of Ras GTPase--evidence for a GTP/GDP displacement model.
    Zhang B; Zhang Y; Shacter E; Zheng Y
    Biochemistry; 2005 Feb; 44(7):2566-76. PubMed ID: 15709769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adenylyl cyclase--isoforms, regulation and function].
    Nowak JZ; Zawilska JB
    Postepy Hig Med Dosw; 1999; 53(2):147-72. PubMed ID: 10355282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenylyl cyclase supersensitivity in opioid-withdrawn NG108-15 hybrid cells requires Gs but is not mediated by the Gsalpha subunit.
    Ammer H; Schulz R
    J Pharmacol Exp Ther; 1998 Aug; 286(2):855-62. PubMed ID: 9694942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.